Anbio Biotechnology (FRA:N3B) Common Stock: €0.01 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:N3B Anbio Biotechnology FRA:N3B
24 GF Score
Price €8.05
! 2 Warning Signs
View Full Analysis

What is Anbio Biotechnology Common Stock?

Anbio Biotechnology FRA:N3B -3.59% 24 Common Stock is €0.01 Mil as of Dec. 2025. GuruFocus rates FRA:N3B with a GF Score™ of 24/100. The stock has 2 warning signs investors should review.

Anbio Biotechnology's quarterly common stock declined from Dec. 2024 (€0.01 Mil) to Jun. 2025 (€0.01 Mil) but then stayed the same from Jun. 2025 (€0.01 Mil) to Dec. 2025 (€0.01 Mil).

Anbio Biotechnology's annual common stock stayed the same from Dec. 2023 (€0.01 Mil) to Dec. 2024 (€0.01 Mil) but then declined from Dec. 2024 (€0.01 Mil) to Dec. 2025 (€0.01 Mil).

Anbio Biotechnology Common Stock Historical Data

* Premium members only.

The historical data trend for Anbio Biotechnology's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Anbio Biotechnology Common Stock Chart

Anbio Biotechnology Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
0.00 0.00 0.01 0.01 0.01

Anbio Biotechnology Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Common Stock Get a 7-Day Free Trial Premium Member Only 0.01 0.01 0.01 0.01 0.01
FRA:N3B
24GF Score
Anbio Biotechnology FRA:N3B
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Anbio Biotechnology Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of €0.01 Mil mean?
Anbio Biotechnology (FRA:N3B) has a Common Stock of €0.01 Mil as of Dec. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Anbio Biotechnology and its competitors.
Is Anbio Biotechnology's Common Stock too high?
Anbio Biotechnology's current Common Stock is €0.01 Mil. Overall, Anbio Biotechnology has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Anbio Biotechnology's Common Stock compare to ANGO and OSUR?
Anbio Biotechnology's Common Stock of €0.01 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Medical Devices & Instruments company?
A good Common Stock depends on the Medical Devices & Instruments industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Anbio Biotechnology and its competitors. Anbio Biotechnology's current Common Stock is €0.01 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Anbio Biotechnology stock overvalued right now?
Anbio Biotechnology (FRA:N3B) has a current Common Stock of €0.01 Mil. The current Common Stock is €0.01 Mil. Anbio Biotechnology's overall GF Score™ is 24/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Anbio Biotechnology (FRA:N3B), the current Common Stock is €0.01 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Anbio Biotechnology Business Description

Other Exchanges NNNN:USA
Address Friedrich-Ebert-Anlage 35-37, Frankfurt am Main, HE, DEU, 60327
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).
24GF Score

Get the complete analysis for FRA:N3B

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€8.05
Price